Low molecular weight heparins (LMWH) are associated with elevated serum potassium levels
Low-molecular-weight heparins (LMWHs), for example, dalteparin, enoxaparin, among others, are anticoagulants. These drugs are used in the prophylaxis of venous thromboembolic disease (VTE) on acute or elective admission to the hospital, and they are used in the treatment of deep vein thromboses...
Effect of low molecular weight heparin(LMWH) and clopidogrel on transient ischemic attack(TIA).; 低分子肝素联合氯吡格雷治疗短暂性脑缺血发作疗效观察 更多例句>> 5) low molecular weight heparins 低分子肝素 1. The clinical study for the patients with unstable angina with low molecular weight hepa...
BLow Molecular Weight Heparins LMWHs have a mean molecular weight of 4000–5000 Da, with a range of 2000-9000 Da (23). They are derived from UFH by chemical or enzymatic depolymerization. Because of the different methods of depolymerization, LMWHs differ inpharmacokineticproperties and anticoagula...
Low-molecular-weight heparins (LMWH) are a class of drugs used for treatment of patients with thrombosis, or blood clots, and as prophylaxis for those who are at risk of thrombosis. They are injectable drugs, usually given sub-cutaneously. Enoxaparin, dalteparin and nadroparin are all examples...
英文名:Low-molecular-weight Heparins Calcium Injection 汉语拼音: 主要成分:由肠粘膜获取的氨基葡聚糖(肝素)片段的钙盐 性状:本品为无色或淡黄色澄明液体。 药理作用:本品的药代动力学由其血浆抗因Xa 活性确定。皮下注射后3小时达到血浆峰值,然后下降,但24小时内仍可监测,半衰期约3.5小时,用药期间抗因子Ⅱa活...
Low molecular weight heparin (LMWH) is an anticoagulant injected subcutaneously or intravenously and acts via activation of antithrombin III which in turn inactivates thrombin and factor Xa to produce its effect. While similar in mechanism to unfractionated heparin, LMWH is cleared renally, has ...
Effect of low molecular weight heparin(LMWH) and clopidogrel on transient ischemic attack(TIA).; 低分子肝素联合氯吡格雷治疗短暂性脑缺血发作疗效观察 更多例句>> 4) low molecular weight heparins 低分子肝素 1. The clinical study for the patients with unstable angina with low molecular weight hepa...
Preparations of low molecular weight heparins (LMWHs) having improved properties, e.g., properties that provide a clinical advantage, are provided herein. Methods of making and using such preparations as well as methods of analyzing starting materials, processing, intermediates and final products in...
Due to their efficient properties and minimal side effects, low molecular weight heparins (LMWHs) are extensively utilized by optimizing their molecular size. Nevertheless, there have been no reports regarding the alleviating effect of LMWHs on PE and the molecular mechanism underlying it. To ...